Search alternatives:
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
marker decrease » marked decrease (Expand Search), larger decrease (Expand Search), marked increase (Expand Search)
means decrease » mean decrease (Expand Search), deaths decreased (Expand Search)
a largest » _ largest (Expand Search), a large (Expand Search), a latest (Expand Search)
a marker » _ marker (Expand Search), _ markers (Expand Search)
5 means » _ means (Expand Search), k means (Expand Search), i means (Expand Search)
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
marker decrease » marked decrease (Expand Search), larger decrease (Expand Search), marked increase (Expand Search)
means decrease » mean decrease (Expand Search), deaths decreased (Expand Search)
a largest » _ largest (Expand Search), a large (Expand Search), a latest (Expand Search)
a marker » _ marker (Expand Search), _ markers (Expand Search)
5 means » _ means (Expand Search), k means (Expand Search), i means (Expand Search)
-
1
-
2
-
3
-
4
A summary of the included study characteristics.
Published 2025“…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”
-
5
Effects of CGA on renal biochemical markers.
Published 2025“…<div><p>Diabetic nephropathy (DN) is the single largest cause of end-stage renal disease (ESRD). Inflammation reaction mediated by NLRP3 inflammasome and Nrf2-related oxidative stress have been considered to play a very important role in the progress of diabetic nephropathy (DN). …”
-
6
-
7
-
8
CM-DWM-EC chart using 30% decrease in the mean for the E(KeV).
Published 2024“…<p>CM-DWM-EC chart using 30% decrease in the mean for the E(KeV).</p>…”
-
9
-
10
-
11
-
12
-
13
List of Included studies.
Published 2025“…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”
-
14
The search strategy in three databases.
Published 2025“…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”
-
15
NIH score.
Published 2025“…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”
-
16
List of excluded studies.
Published 2025“…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”
-
17
Astrocytes increase contact with vessels and expression of AQP4 following Mtb infection, which is decreased in cytosis<sup>+</sup> animals.
Published 2024“…Representative images of the frontal cortex (A–D), cerebral nuclei (G–J), brain stem (M–P), thalamus (S–V), and hippocampus (Y–BB) 15 days post-infection are shown. …”
-
18
-
19
Claudin V is decreased following infection with Mtb.
Published 2024“…Exposure to Mtb H37Rv and HN878 decreased claudin V expression compared to uninfected controls in the frontal cortex (E), cerebral nuclei (J), brain stem (O), thalamus (T), and hippocampus (Y). …”
-
20